Cristoforo Comi
← Back to Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
Cristoforo Comi works in Multiple Sclerosis Research Studies, Parkinson's Disease Mechanisms and Treatments, Dementia and Cognitive Impairment Research, Peripheral Neuropathies and Disorders, Neuroinflammation and Neurodegeneration Mechanisms. Recorded institutional associations include Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliero Universitaria Maggiore della Carita.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
2021 · 535 citationsParkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
2018 · 278 citationsIntensive Rehabilitation Treatment in Early Parkinson’s Disease
2014 · 184 citationsExpression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis
2011 · 176 citationsLow-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
2018 · 170 citationsPhase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
2009 · 158 citationsOsteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
2016 · 156 citationsSubcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis
2014 · 155 citationsIntensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients
2013 · 153 citationsA nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy
2009 · 149 citationsProbiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
2019 · 144 citationsLRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
2018 · 143 citationsFatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients
2020 · 139 citationsRituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature
2010 · 126 citationsOsteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline
2010 · 123 citationsExploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
2019 · 119 citationsEffectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients
2011 · 116 citationsDefective T cell Fas function in patients with multiple sclerosis
2000 · 113 citationsDopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
2016 · 104 citationsImmunity and inflammation in neurodegenerative diseases.
2013 · 100 citationsAntiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
2018 · 97 citationsPeripheral nervous system involvement in Parkinson's disease: Evidence and controversies
2014 · 89 citationsPrevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens
2013 · 89 citationsOxidative Stress in Non-Alcoholic Fatty Liver Disease
2022 · 89 citationsTAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
2019 · 88 citations
